Trial Profile

Pharmacokinetic and pharmacodynamic single dose study of sitagliptin in healthy Indian male subjects

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 14 Mar 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Sitagliptin (Primary)
Indications Type 2 diabetes mellitus
Focus Pharmacodynamics; Pharmacokinetics

Most Recent Events

06 Mar 2018 Results assessing PK/PD profile of single-dose sitagliptin 100 mg (Januvia) in healthy Indian male and also compared with non-Indian population, presented in the European Journal of Clinical Pharmacology.
18 Jul 2017 New trial record
13 Jun 2017 Results presented at the 77th Annual Scientific Sessions of the American Diabetes Association

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com